NYSE:MED Medifast (MED) Stock Forecast, Price & News $77.35 +0.73 (+0.95%) (As of 12:55 PM ET) Add Compare Share Share Today's Range$76.46▼$77.4650-Day Range$76.56▼$106.9352-Week Range$76.46▼$131.42Volume41,541 shsAverage Volume198,193 shsMarket Capitalization$842.34 millionP/E Ratio6.38Dividend Yield8.53%Price Target$80.00 ProfileProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Medifast MarketRank™ ForecastAnalyst RatingHold2.00 Rating ScoreUpside/Downside3.8% Upside$80.00 Price TargetShort InterestBearish15.54% of Float Sold ShortDividend StrengthModerateBased on Four FactorsSustainability-4.08Upright™ Environmental ScoreNews Sentiment0.54Based on 2 Articles This WeekInsider TradingSelling Shares$1.40 M Sold Last QuarterProj. Earnings Growth-13.33%From $8.78 to $7.61 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.59 out of 5 starsConsumer Staples Sector125th out of 135 stocksMiscellaneous Food Preparations & Kindred Products Industry4th out of 4 stocks 1.0 Analyst's Opinion Consensus RatingMedifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $80.00, Medifast has a forecasted upside of 3.8% from its current price of $77.06.Amount of Analyst CoverageMedifast has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted15.54% of the float of Medifast has been sold short.Short Interest Ratio / Days to CoverMedifast has a short interest ratio ("days to cover") of 9.5.Change versus previous monthShort interest in Medifast has recently increased by 1.84%, indicating that investor sentiment is decreasing. Previous Next 2.5 Dividend Strength Dividend LeadershipMedifast is a leading dividend payer. It pays a dividend yield of 8.59%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthMedifast has only been increasing its dividend for 3 years.Dividend CoverageThe dividend payout ratio of Medifast is 54.46%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on EPS estimates, Medifast will have a dividend payout ratio of 86.73% in the coming year. This indicates that Medifast may not be able to sustain their current dividend. Previous Next 2.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreMedifast has received a 4.84% net impact score from Upright. The largest positive contribution comes from its "Nutrition" impact, which is mostly driven by its "Meal replacement drinks", "Granola without added sugar", and "Protein shakes" products. See details.Environmental SustainabilityThe Environmental Impact score for Medifast is -4.08. Previous Next 1.4 News and Social Media Coverage News SentimentMedifast has a news sentiment score of 0.54. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Consumer Staples companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Medifast this week, compared to 3 articles on an average week.Search InterestOnly 15 people have searched for MED on MarketBeat in the last 30 days. This is a decrease of -44% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added Medifast to their MarketBeat watchlist in the last 30 days. This is a decrease of -13% compared to the previous 30 days. Previous Next 3.3 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Medifast insiders have sold 1,826.10% more of their company's stock than they have bought. Specifically, they have bought $72,855.00 in company stock and sold $1,403,260.00 in company stock.Percentage Held by InsidersOnly 2.06% of the stock of Medifast is held by insiders.Percentage Held by Institutions87.83% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Medifast are expected to decrease by -13.33% in the coming year, from $8.78 to $7.61 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Medifast is 6.36, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 117.43.Price to Earnings Ratio vs. SectorThe P/E ratio of Medifast is 6.36, which means that it is trading at a less expensive P/E ratio than the Consumer Staples sector average P/E ratio of about 18.47.Price to Book Value per Share RatioMedifast has a P/B Ratio of 5.43. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Medifast (NYSE:MED) StockMedifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland.Read More MED Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MED Stock News HeadlinesSeptember 20, 2023 | marketbeat.comAre These Consumer Staples Too Cheap for Investors To Ignore? (MED)The consumer staples sector is beaten down and offering a significant value and high yield for long-term-minded investorsSeptember 24, 2023 | americanbankingnews.comMedifast (NYSE:MED) Hits New 12-Month Low at $77.46September 28, 2023 | Wall Street Fundamentals (Ad)Would Buffett Approve of This Growth Strategy?Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.September 18, 2023 | finance.yahoo.com30 Most Overweight and Obese Cities in the U.S. In 2023September 18, 2023 | finance.yahoo.comMedifast Inc (MED): A Deep Dive into its Dividend PerformanceSeptember 17, 2023 | finance.yahoo.comWhat Is Medifast, Inc.'s (NYSE:MED) Share Price Doing?September 13, 2023 | benzinga.comFriday Is Your Last Chance To Buy Medifast Before The Dividend PayoutSeptember 13, 2023 | finance.yahoo.comOPTAVIA ACTIVE™ Now AvailableSeptember 28, 2023 | Wall Street Fundamentals (Ad)Would Buffett Approve of This Growth Strategy?Warren Buffett's approach has been to find and invest in undervalued businesses with strong potential for growth. Taking this approach to heart and applying it to a Trillion Dollar industry has proved itself in a big way...achieving an incredible 400+% growth during a down market.September 7, 2023 | finance.yahoo.comMedifast Survey Finds 8 out of 10 U.S. Adults say Practicing Daily "Self-Care Habits" is a PrioritySeptember 6, 2023 | finance.yahoo.comWhy Is Medifast (MED) Down 7.4% Since Last Earnings Report?August 21, 2023 | finance.yahoo.comWant $500 in Passive Income? 2 High-Dividend Stocks to Snap UpAugust 9, 2023 | finance.yahoo.comMedifast plans to expand into sports nutrition as revenue declinesAugust 9, 2023 | finance.yahoo.comMedifast, Inc. (NYSE:MED) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?August 9, 2023 | finanznachrichten.deMedifast, Inc.: Medifast Announces Second Quarter 2023 Financial ResultsAugust 8, 2023 | msn.comMedifast's (MED) Q2 Earnings Top Estimates, Sales Decline Y/YAugust 8, 2023 | finance.yahoo.comQ2 2023 Medifast Inc Earnings CallAugust 8, 2023 | msn.comMedifast GAAP EPS of $2.77 beats by $1.33, revenue of $296.19M beats by $25.99MAugust 8, 2023 | finance.yahoo.comMedifast Announces Second Quarter 2023 Financial ResultsAugust 8, 2023 | finance.yahoo.comMedifast (MED) Q2 Earnings and Revenues Surpass EstimatesAugust 7, 2023 | seekingalpha.comMedifast, Inc. 2023 Q2 - Results - Earnings Call PresentationAugust 4, 2023 | msn.comMedifast: Take Advantage Of Pessimism Over Weight Loss DrugsAugust 3, 2023 | finance.yahoo.comMedifast (MED) Queued for Q2 Earnings: Things to ConsiderAugust 1, 2023 | nasdaq.comDA Davidson Maintains Medifast (MED) Neutral RecommendationJuly 28, 2023 | stockhouse.comMedifast Expands into $30B Sports Nutrition Category with OPTAVIA ACTIVE(TM)July 28, 2023 | finance.yahoo.comMedifast Expands into $30B Sports Nutrition Category with OPTAVIA ACTIVE™July 24, 2023 | finance.yahoo.comMedifast to Announce Financial Results for the Second Quarter Ended June 30, 2023See More Headlines Receive MED Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. Email Address MED Company Calendar Ex-Dividend for 8/8 Dividend6/26/2023Last Earnings8/07/2023Dividend Payable8/08/2023Ex-Dividend for 11/7 Dividend9/18/2023Today9/28/2023Next Earnings (Estimated)11/02/2023Dividend Payable11/07/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE Industry Miscellaneous food preparations & kindred products Sub-IndustryPersonal Products SectorConsumer Staples Current SymbolNYSE:MED CUSIP58470H10 CIK910329 Webwww.medifast1.com Phone(410) 581-8042Fax410-581-8070Employees874Year FoundedN/APrice Target and Rating Average Stock Price Forecast$80.00 High Stock Price Forecast$80.00 Low Stock Price Forecast$80.00 Forecasted Upside/Downside+4.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$12.12 Trailing P/E Ratio6.32 Forward P/E Ratio8.72 P/E GrowthN/ANet Income$143.57 million Net Margins9.68% Pretax Margin12.58% Return on Equity89.20% Return on Assets46.03% Debt Debt-to-Equity RatioN/A Current Ratio1.99 Quick Ratio1.39 Sales & Book Value Annual Sales$1.60 billion Price / Sales0.52 Cash Flow$15.72 per share Price / Cash Flow4.87 Book Value$14.19 per share Price / Book5.40Miscellaneous Outstanding Shares10,890,000Free Float10,665,000Market Cap$833.74 million OptionableOptionable Beta1.24 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Daniel R. Chard (Age 58)Exec. Chairman & CEO Comp: $1.94MMr. James P. Maloney CPA (Age 55)Chief Financial Officer Comp: $823.91kMr. Anthony E. Tyree (Age 58)Chief Bus. Operations Officer Comp: $655.86kMr. Jason L. Groves Esq. (Age 52)Exec. VP, Gen. Counsel & Corp. Sec. Comp: $669.51kMr. Nicholas M. Johnson (Age 43)Chief Field Operations Officer Comp: $696.4kMr. Jonathan Barrett MacKenzie (Age 51)VP of Fin. & Chief Accounting Officer Mr. Steven ZenkerVP of Investor RelationsMs. Claudia C. Greninger (Age 50)Chief HR Officer More ExecutivesKey CompetitorsUtz BrandsNYSE:UTZArkoNASDAQ:ARKOChefs' WarehouseNASDAQ:CHEFUnited Natural FoodsNYSE:UNFIThe Hain Celestial GroupNASDAQ:HAINView All CompetitorsInsiders & InstitutionsDean Capital ManagementBought 1,105 shares on 8/23/2023Ownership: 0.111%Wolverine Trading LLCSold 8,200 shares on 8/23/2023Ownership: 0.000%Virginia Retirement Systems ET ALBought 15,200 shares on 8/22/2023Ownership: 0.140%California State Teachers Retirement SystemSold 530 shares on 8/21/2023Ownership: 0.120%Teachers Retirement System of The State of KentuckyBought 193 shares on 8/21/2023Ownership: 0.033%View All Insider TransactionsView All Institutional Transactions MED Stock - Frequently Asked Questions Should I buy or sell Medifast stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" MED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MED, but not buy additional shares or sell existing shares. View MED analyst ratings or view top-rated stocks. What is Medifast's stock price forecast for 2023? 1 brokerages have issued 1 year price objectives for Medifast's shares. Their MED share price forecasts range from $80.00 to $80.00. On average, they expect the company's share price to reach $80.00 in the next twelve months. This suggests a possible upside of 4.5% from the stock's current price. View analysts price targets for MED or view top-rated stocks among Wall Street analysts. How have MED shares performed in 2023? Medifast's stock was trading at $115.35 at the beginning of 2023. Since then, MED shares have decreased by 33.6% and is now trading at $76.56. View the best growth stocks for 2023 here. When is Medifast's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, November 2nd 2023. View our MED earnings forecast. How were Medifast's earnings last quarter? Medifast, Inc. (NYSE:MED) released its quarterly earnings data on Monday, August, 7th. The specialty retailer reported $2.77 EPS for the quarter, beating analysts' consensus estimates of $1.44 by $1.33. The specialty retailer had revenue of $296.20 million for the quarter, compared to analysts' expectations of $270.20 million. Medifast had a net margin of 9.68% and a trailing twelve-month return on equity of 89.20%. Medifast's revenue for the quarter was down 34.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $3.87 EPS. How often does Medifast pay dividends? What is the dividend yield for Medifast? Medifast announced a quarterly dividend on Thursday, September 7th. Shareholders of record on Tuesday, September 19th will be paid a dividend of $1.65 per share on Tuesday, November 7th. This represents a $6.60 dividend on an annualized basis and a yield of 8.62%. The ex-dividend date of this dividend is Monday, September 18th. Read our dividend analysis for MED. What ETFs hold Medifast's stock? ETFs with the largest weight of Medifast (NYSE:MED) stock in their portfolio include Invesco S&P SmallCap Consumer Staples ETF (PSCC), First Trust SMID Cap Rising Dividend Archievers ETF (SDVY), Roundhill Acquirers Deep Value ETF (DEEP), Pacer US Small Cap Cash Cows 100 ETF (CALF), Invesco S&P SmallCap Quality ETF (XSHQ), WisdomTree U.S. SmallCap Quality Dividend Growth Fund (DGRS), Royce Quant Small-Cap Quality Value ETF (SQLV) and Global X Health & Wellness ETF (BFIT). Is Medifast a good dividend stock? Medifast (NYSE:MED) pays an annual dividend of $6.60 per share and currently has a dividend yield of 8.49%. MED has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 54.46%. This payout ratio is at a healthy, sustainable level, below 75%. Based on EPS estimates, MED will have a dividend payout ratio of 86.73% in the coming year. This indicates that the company may not be able to sustain their current dividend. Read our dividend analysis for MED. What guidance has Medifast issued on next quarter's earnings? Medifast issued an update on its third quarter 2023 earnings guidance on Monday, August, 7th. The company provided EPS guidance of $0.71-$1.32 for the period, compared to the consensus EPS estimate of $1.43. The company issued revenue guidance of $220.00 million-$240.00 million, compared to the consensus revenue estimate of $269.57 million. What is Daniel Chard's approval rating as Medifast's CEO? 44 employees have rated Medifast Chief Executive Officer Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among the company's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Medifast own? Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM). What is Medifast's stock symbol? Medifast trades on the New York Stock Exchange (NYSE) under the ticker symbol "MED." Who are Medifast's major shareholders? Medifast's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (15.70%), Renaissance Technologies LLC (6.25%), State Street Corp (3.51%), Dimensional Fund Advisors LP (3.10%), Pacer Advisors Inc. (2.22%) and Geode Capital Management LLC (2.08%). Insiders that own company stock include Andrea B Thomas, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Jeffrey J Brown, Kevin G Byrnes, Michael C Macdonald and Scott Schlackman. View institutional ownership trends. How do I buy shares of Medifast? Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Medifast's stock price today? One share of MED stock can currently be purchased for approximately $76.56. How much money does Medifast make? Medifast (NYSE:MED) has a market capitalization of $833.74 million and generates $1.60 billion in revenue each year. The specialty retailer earns $143.57 million in net income (profit) each year or $12.12 on an earnings per share basis. How many employees does Medifast have? The company employs 874 workers across the globe. How can I contact Medifast? Medifast's mailing address is 100 International Drive, Baltimore MD, 21202. The official website for the company is www.medifast1.com. The specialty retailer can be reached via phone at (410) 581-8042, via email at ir@choosemedifast.com, or via fax at 410-581-8070. This page (NYSE:MED) was last updated on 9/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.